If you want different results, do not do the same things

Albert Einstein

About Nanokide Therapeutics

Nanokide Therapeutics is a biotechnology company focused on the development of novel antimetastatic solutions based on the combination of nanotechnology and microRNA and mRNA.

Our nanosystems is a flexible, non-toxic and easy to produce formulation that combined with microRNA and mRNA sequences offer a perfect platform for anticancer drugs development.

Team

Maitane Duarte

CSO and Founder

MD Biology / Researcher

Iker Badiola

CEO and Founder

PhD in Biology / Assistant professor in UPV/EHU

Majid Khatib

Founder

PhD in Biology/ INSERM

Our Technology

The core of our technology is the combination of a flexible nanosystem with microRNA and mRNA therapy against cancer.
The nanosystem developed by Nanokide is based on sorbitan ester.

‎

  •  

    Antiangiogenic therapy

    Mi-20a is a small non-coding RNA downregulated in liver sinusoidal endothelial cells during liver metastasis. Span-based nanoparticles loaded with miR-20a and decorated with chondroitin sulfate can introduce the missing miR-20a specifically in the liver sinusoidal endothelial cells blocking the angiogenic process.

ARTICLES

Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver

Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems

Xanthan gum-functionalised span nanoparticles for gene targeting to endothelial cells

NEWS

13/07/2022

NIH granted Nanokide

The NCL has selected our technology Span-based nanoparticles loaded with miR-20a for the preclinical development program

Read More
11/07/2022

Toribio Echevarria Awards

Nanokide awarded as finalist in the Business Ideas/Projects section of the Toribio Echevarria 2022 awards.

Read More
16/09/2022

Cantábrico Excelente Awards

Nanokide Therapeutics awarded in the category of best R+D+i company in the VI edition of the Cantabrian Excellent Awards.

Read More
20/07/2022

"Our nanoparticle blocks tumor growth"

Interview in the newspaper Berria

Read More
20/10/2022

Nanokide in B-Venture 2022

Nanokid Therapeutics participated in B-Venture 2022 in Bilbao from 18th to 19th of October

Read More

AWARDS

Finalist Toribio Echevarria Awards 2022

Awarded Cantábrico de Excelencia Award 2022

Nominated DEIA VODAFONE INNOVATION Award 2022

Contact

  • Ed. Rectorado – Planta baja Campus de Bizkaia. Sarriena s/n. 48940 Leioa

⠀

Videos, images and gifs made by Rosario García Hernández